Back

Arrhythmic burden and sudden cardiac death across cardiomyopathy phenotypes in the contemporary implantable cardioverter-defibrillator era

29 August 2026 (10:25 - 11:05)
Organised by: Logo
Congress Presentation Part of: Enhancing understanding across the spectrum of myocardial disease Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Vasiliki Gardikioti

Ippokrateio General Hospital of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Sex differences in clinical characteristics and outcomes of Takotsubo syndrome in an east asian population
Doctor K. Miyakoda (JP)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of primary vs. secondary takotsubo syndrome
Doctor M. Kitagawa (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Mechanical dispersion and ventricular arrhythmia burden in wild-type transthyretin cardiomyopathy
Doctor D. Faro (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Repolarization patterns in right-sided precordial leads in relation to genotype and structural substrate in patients with arrhythmogenic right ventricular cardiomyopathy
Doctor A. Savelev (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Influence of exercise on arrhythmogenic right ventricular cardiomyopathy associated with the p.Ser329Argfs*23 PKP2 variant
Mr G. Gonzalez Barbeito (A Coruna, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Enhancing understanding across the spectrum of myocardial disease

The Event

Event poster

ESC Congress 2026

29 August 2026 10:25 CET
You may be interested in
thumbnail
Congress Presentation
Phenotype- and genotype-specific dominance of arrhythmic versus heart failure trajectories in inherited cardiomyopathies
29 August 2026
thumbnail
Congress Presentation
Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation
5 April 2022
thumbnail
Congress Presentation
Long-term outcomes of subcutaneous ICD therapy in arrhythmogenic cardiomyopathy: a multicentre cohort study
31 August 2026
thumbnail
Congress Presentation
Head-to-head comparison of ESC 2023 and 2024 ACC/AHA primary-prevention ICD selection strategies in hypertrophic cardiomyopathy: insights from a real-world ICD-implanted cohort
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources